Thomas Buhl

1.1k total citations
25 papers, 879 citations indexed

About

Thomas Buhl is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Thomas Buhl has authored 25 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Thomas Buhl's work include Synthesis and biological activity (9 papers), Melanoma and MAPK Pathways (6 papers) and Protease and Inhibitor Mechanisms (4 papers). Thomas Buhl is often cited by papers focused on Synthesis and biological activity (9 papers), Melanoma and MAPK Pathways (6 papers) and Protease and Inhibitor Mechanisms (4 papers). Thomas Buhl collaborates with scholars based in Switzerland, United States and Netherlands. Thomas Buhl's co-authors include Roland Feifel, Láśzló Révész, Karl‐Heinz Buchheit, Peter Hiestand, Franco E. Di Padova, Ute Manning, Hermann Gram, Ulf Neumann, Jens J. Holst and Hans Kofod and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Thomas Buhl

25 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Buhl Switzerland 18 314 294 179 101 92 25 879
Bruce A. Lefker United States 22 539 1.7× 452 1.5× 151 0.8× 48 0.5× 123 1.3× 40 1.3k
Esther Y. Chao United States 11 546 1.7× 132 0.4× 80 0.4× 50 0.5× 165 1.8× 15 881
Corinne E. Augelli‐Szafran United States 21 599 1.9× 221 0.8× 78 0.4× 89 0.9× 37 0.4× 62 1.1k
Jean‐Pierre Gotteland United States 20 386 1.2× 223 0.8× 73 0.4× 34 0.3× 87 0.9× 51 1.1k
Iain Uings United Kingdom 21 484 1.5× 91 0.3× 144 0.8× 85 0.8× 215 2.3× 41 1.2k
Péter Arányi Hungary 17 305 1.0× 127 0.4× 48 0.3× 60 0.6× 124 1.3× 76 753
Roland Feifel Switzerland 21 769 2.4× 338 1.1× 164 0.9× 118 1.2× 25 0.3× 36 1.3k
Sylvie Y. Blond United States 19 741 2.4× 192 0.7× 83 0.5× 43 0.4× 149 1.6× 29 1.1k
Laura Lucarini Italy 22 649 2.1× 281 1.0× 103 0.6× 66 0.7× 128 1.4× 55 1.2k
Puranik Purushottamachar United States 18 669 2.1× 165 0.6× 145 0.8× 137 1.4× 181 2.0× 45 1.0k

Countries citing papers authored by Thomas Buhl

Since Specialization
Citations

This map shows the geographic impact of Thomas Buhl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Buhl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Buhl more than expected).

Fields of papers citing papers by Thomas Buhl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Buhl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Buhl. The network helps show where Thomas Buhl may publish in the future.

Co-authorship network of co-authors of Thomas Buhl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Buhl. A scholar is included among the top collaborators of Thomas Buhl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Buhl. Thomas Buhl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
John, Markus R., Leo Widler, R. Gamse, et al.. (2011). ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans. Bone. 49(2). 233–241. 32 indexed citations
2.
Gerspacher, Marc, Pascal Furet, Carole Pissot‐Soldermann, et al.. (2010). 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1724–1727. 21 indexed citations
3.
Gerspacher, Marc, Eva Altmann, Thomas Buhl, et al.. (2010). Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists). Bioorganic & Medicinal Chemistry Letters. 20(17). 5161–5164. 9 indexed citations
4.
Altmann, Eva, Reiner Aichholz, Claudia Betschart, et al.. (2007). 2-Cyano-pyrimidines:  A New Chemotype for Inhibitors of the Cysteine Protease Cathepsin K. Journal of Medicinal Chemistry. 50(4). 591–594. 23 indexed citations
5.
Janser, Philipp, Ulf Neumann, Wolfgang Miltz, Roland Feifel, & Thomas Buhl. (2006). A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(10). 2632–2636. 11 indexed citations
6.
Altmann, Eva, Reiner Aichholz, Claudia Betschart, et al.. (2006). Dipeptide nitrile inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 16(9). 2549–2554. 19 indexed citations
7.
Révész, Láśzló, Birgit Bollbuck, Thomas Buhl, et al.. (2006). Bridged Piperazines and Piperidines as CCR1 Antagonists with Oral Activity in Models of Arthritis and Multiple Sclerosis. Letters in Drug Design & Discovery. 3(10). 689–694. 7 indexed citations
8.
Waelchli, Rudolf, Birgit Bollbuck, Christian Bruns, et al.. (2005). Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK. Bioorganic & Medicinal Chemistry Letters. 16(1). 108–112. 121 indexed citations
9.
Révész, Láśzló, Birgit Bollbuck, Thomas Buhl, et al.. (2005). Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis. Bioorganic & Medicinal Chemistry Letters. 15(23). 5160–5164. 24 indexed citations
10.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2005). Pyrazoloheteroaryls: Novel p38α MAP kinase inhibiting scaffolds with oral activity. Bioorganic & Medicinal Chemistry Letters. 16(2). 262–266. 63 indexed citations
11.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2004). Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis. Bioorganic & Medicinal Chemistry Letters. 14(13). 3595–3599. 51 indexed citations
12.
Meli, Damian N., Jutta M. Loeffler, Ulf Neumann, et al.. (2004). In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-α converting enzyme attenuates seizures and injury of the cerebral cortex. Journal of Neuroimmunology. 151(1-2). 6–11. 61 indexed citations
13.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2004). SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activity. Bioorganic & Medicinal Chemistry Letters. 14(13). 3601–3605. 26 indexed citations
14.
15.
Renaud, Johanne, Serge Bischoff, Thomas Buhl, et al.. (2003). Estrogen Receptor Modulators:  Identification and Structure−Activity Relationships of Potent ERα-Selective Tetrahydroisoquinoline Ligands. Journal of Medicinal Chemistry. 46(14). 2945–2957. 75 indexed citations
16.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2002). SAR of 2,6-diamino-3,5-difluoropyridinyl substituted heterocycles as novel p38MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(16). 2109–2112. 48 indexed citations
17.
Révész, Láśzló, Franco E. Di Padova, Thomas Buhl, et al.. (2000). SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(11). 1261–1264. 41 indexed citations
18.
Buhl, Thomas, et al.. (1994). Stimulant effects of 5-hydroxytryptamine on guinea pig stomach preparations in vitro. European Journal of Pharmacology. 262(1-2). 91–97. 32 indexed citations
19.
Buchheit, Karl‐Heinz & Thomas Buhl. (1991). Prokinetic benzamides stimulate peristaltic activity in the isolated guinea pig ileum by activation of 5-HT4 receptors. European Journal of Pharmacology. 205(2). 203–208. 59 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce A. Lefker Breakdown of academic impact, for papers by Esther Y. Chao Breakdown of academic impact, for papers by Corinne E. Augelli‐Szafran Breakdown of academic impact, for papers by Jean‐Pierre Gotteland Breakdown of academic impact, for papers by Iain Uings Breakdown of academic impact, for papers by Péter Arányi Breakdown of academic impact, for papers by Roland Feifel Breakdown of academic impact, for papers by Sylvie Y. Blond Breakdown of academic impact, for papers by Laura Lucarini Breakdown of academic impact, for papers by Puranik Purushottamachar
Rankless by CCL
2026